These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9730150)
41. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Gerding MN; Prummel MF; Wiersinga WM Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345 [TBL] [Abstract][Full Text] [Related]
42. Serum levels of soluble Fas in patients with Graves' ophthalmopathy. Ohtsuka K; Hashimoto M Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108 [TBL] [Abstract][Full Text] [Related]
43. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899 [TBL] [Abstract][Full Text] [Related]
44. Place of radiotherapy in the treatment of Graves' orbitopathy. Beckendorf V; Maalouf T; George JL; Bey P; Leclere J; Luporsi E Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):805-15. PubMed ID: 10098436 [TBL] [Abstract][Full Text] [Related]
51. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Kung AW; Michon J; Tai KS; Chan FL Thyroid; 1996 Oct; 6(5):381-4. PubMed ID: 8936659 [TBL] [Abstract][Full Text] [Related]
52. Radiotherapy for Graves' ophthalmopathy: results at one year. Gorman CA Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049 [TBL] [Abstract][Full Text] [Related]
53. New immunomodulators in the treatment of Graves' ophthalmopathy. Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090 [TBL] [Abstract][Full Text] [Related]
54. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821 [TBL] [Abstract][Full Text] [Related]
56. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis. Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881 [TBL] [Abstract][Full Text] [Related]
57. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement. Yamamoto K; Saito K; Takai T; Yoshida S Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533 [TBL] [Abstract][Full Text] [Related]
58. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946 [TBL] [Abstract][Full Text] [Related]
59. Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results. Olivotto IA; Ludgate CM; Allen LH; Rootman J Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2085-90. PubMed ID: 3840786 [TBL] [Abstract][Full Text] [Related]